Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Pike

Showing results (321-330 of 352) with videos related to

Pageof 36
Sort By:
Cancer Research|August 27, 1999
Cytochrome P450c17alpha gene (CYP17) polymorphism predicts use of hormone replacement therapyH S Feigelson, R McKean-Cowdin, M C Pike, et al.
British Journal of Cancer|January 1, 1977
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examplesR Peto, M C Pike, P Armitage, et al.
British Journal of Cancer|December 1, 1976
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and designR Peto, M C Pike, P Armitage, et al.
Atherosclerosis|February 1, 1992
A prospective study of obesity, lipids, apolipoproteins and ischaemic heart disease in womenM P Coleman, T J Key, D Y Wang, et al.
The American Journal of Clinical Nutrition|December 16, 1998
Soy intake and risk of breast cancer in Asians and Asian AmericansA H Wu, R G Ziegler, A M Nomura, et al.
Cancer|December 1, 1991
Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survivalA M Levine, J Sullivan-Halley, M C Pike, et al.
British Journal of Cancer|June 1, 1996
A prospective study of urinary oestrogen excretion and breast cancer riskT J Key, D Y Wang, J B Brown, et al.
Cancer Research|November 1, 1994
Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosisM F Press, M C Pike, G Hung, et al.
Cancer Research|October 27, 1998
Androgen metabolism and prostate cancer: establishing a model of genetic susceptibilityR K Ross, M C Pike, G A Coetzee, et al.
Blood|August 15, 1993
Effect on lymphocyte subsets of clotting factor therapy in human immunodeficiency virus-1-negative congenital clotting disorders. The Transfusion Safety Study GroupJ Hassett, G F Gjerset, J W Mosley, et al.
Pageof 36

Showing results (321-330 of 352) with videos related to

Sort By:
Pageof 36
Cancer Research|August 27, 1999
Cytochrome P450c17alpha gene (CYP17) polymorphism predicts use of hormone replacement therapyH S Feigelson, R McKean-Cowdin, M C Pike, et al.
British Journal of Cancer|January 1, 1977
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examplesR Peto, M C Pike, P Armitage, et al.
British Journal of Cancer|December 1, 1976
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and designR Peto, M C Pike, P Armitage, et al.
Atherosclerosis|February 1, 1992
A prospective study of obesity, lipids, apolipoproteins and ischaemic heart disease in womenM P Coleman, T J Key, D Y Wang, et al.
The American Journal of Clinical Nutrition|December 16, 1998
Soy intake and risk of breast cancer in Asians and Asian AmericansA H Wu, R G Ziegler, A M Nomura, et al.
Cancer|December 1, 1991
Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survivalA M Levine, J Sullivan-Halley, M C Pike, et al.
British Journal of Cancer|June 1, 1996
A prospective study of urinary oestrogen excretion and breast cancer riskT J Key, D Y Wang, J B Brown, et al.
Cancer Research|November 1, 1994
Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosisM F Press, M C Pike, G Hung, et al.
Cancer Research|October 27, 1998
Androgen metabolism and prostate cancer: establishing a model of genetic susceptibilityR K Ross, M C Pike, G A Coetzee, et al.
Blood|August 15, 1993
Effect on lymphocyte subsets of clotting factor therapy in human immunodeficiency virus-1-negative congenital clotting disorders. The Transfusion Safety Study GroupJ Hassett, G F Gjerset, J W Mosley, et al.
Pageof 36